Znaczenie prawidlowego zywienia kobiety w czasie ciazy

• Autorzy: Szostak-Wegierek D

Warianty tytułu

EN

Importance of adequate nutrition during pregnancy

• Języki publikacji: PL

Słowa kluczowe

PL

masa ciala; bialko; zelazo; kobiety ciezarne; kwas foliowy; przyrost masy ciala; przeciwutleniacze; witaminy; kwasy tluszczowe; zywienie racjonalne; wapn; cynk; magnez; izomery trans; zywienie czlowieka; jod

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2004
• Tom: 31
• Numer: 2
• Opis fizyczny: s.160-171,tab.,bibliogr.

Twórcy

autor

Szostak-Wegierek D

• Instytut Zywnosci i Zywienia, Warszawa

Bibliografia

• 1. Abrams B.F., Laros R.K.Jr.: Prepregnancy weight, weight gain, and birth weight. Am. J. Obstet. Gynecol., 1986, 154, 503-509.
• 2. Agarwal K.N., Agarwal D.K., Mishra K.P: Impact of anaemia prophylaxis in pregnancy on maternal hemoglobin, serum ferritin and birth weight. Indian J. Med. Res., 1991, 94, 277-80.
• 3. Al M.D.M., van Houwelingen A.C., Kester A.D.M. et al.: Maternal essential fatty acid patterns during normal pregnancy and its relationship with the neonatal essential fatty acid status. Br. J. Nutr., 1995, 74, 55-68.
• 4. Allen L.H.: Pregnancy and iron deficiency: unresolved issues. Nutr. Rev., 1997, 55, 91-101.
• 5. Arnold R.W.: Retinopathy of prematurity in Alaska. In: Proceedings of the 19th Annual Providence Hospital Perinatal Symposium, Anchorage, AL, 1992.
• 6. Bailey L.B.: Folate requirements and dietary recommendations. In: Folate in health and disease. Ed: L.B. Bailey. New York Marcel Dekker, 1995.
• 7. Barker D.J.P.: Mothers, babies and disease in later life. London, Br. Med. J. Publishing Group,1994.
• 8. Bazan N.G.: The metabolism of omega-3 polyunsaturated fatty acids in the eye: The possible role of docosahexaenoic acid and docosanoids in retinal physiology and ocular pathology. Prog. Clin. Biol. Res., 1989, 312, 95.
• 9. Belizan J.M., Villar J., Gonzales L. et al.: Calcium supplementation to prevent hypertensive disorders of pregnancy. N. Engl. J. Med., 1991, 325, 1399-1405.
• 10. Birch E.E., Birch D.G., Hoffman D.R. et al.: Dietary essential fatty acid supply and visual acuity development. Invest. Ophth. Vis. Sei., 1992, 33, 3242.
• 11. Birch D.G., Birch E.E., Hoffman D.R. et al.: Retinal development in verylow-birth-weight infants fed diets differing in omega-3 fatty acids. Invest. Ophthalmol. Vis. Sei 1992, 33, 2365.
• 12. Bower C., Stanley F.J.: Dietary folate as a risk factor for neural tube defects: evidence from a case control study in estern Australia. Med. J. Aust. 1989, 150, 613.
• 13. Brown J.E., Murtaugh M.A., Jacobs D.R.,Jr et al.: Variation in newborn size according to pregnancy weight change by trimester. Am. J. Clin. Nutr., 2002, 76, 205-9.
• 14. Brzeziński Z.J., Mazurczak T.: Propozycje wprowadzenia profilaktyki pierwotnej wad rozwojowych cewy nerwowej w Polsce. Ped. Pol., 1994, 69, 684.
• 15. Bucher H.C., Guyatt G.H., Cook R.J. et al.: Effect of calcium supplementation on pregnancy-induced hypertention and preeclampsia: a meta-analysis of randomized controlled trials. J. Am. Med. Assoc., 1996, 275, 1113- 7.
• 16. Bunin G.R., Kuijten R.R., Buckley J.D. et al.: Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N. Engl. J. Med., 1993, 329, 536.
• 17. Chien P.F.W, Khan K.S., Arnott N.: Magnesium sulphate in the treatment of eclampsia and pre-eclampsia: an overview of the evidence from randomized trials. Br. J. Obstet. Gynecol., 1996, 103, 1085-91.
• 18. Colomer J: Anaemia during pregnancy as a risk factor for infant iron deficiency: report from the Valencia Infant Anaemia Cohort (VIAC) study. Paediatr. Perinat. Epidemiol., 1990, 4, 196-204.
• 19. Conradt A., Weidinger H., Algayer H.: Magnesium therapy decreased the rate if intrauterine fetal retardation, premature rupture of membranes and premature delivery in risk pregnancies treated with betamimetics. Magnesium, 1985, 4, 20-28.
• 20. Cuskelly G.J., McNulty H., Scott J.M.: Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet, 1996, 347, 657-9.
• 21. Czeizel A.E., Dudas I.: Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N. Engl. J.Med. 1992, 327, 1832- 5.
• 22. Delange F.: Administration of iodized oil during pregnancy: a summary of published evidence. Bull. WHO 1996, 74, 101-108.
• 23. De Maeyer E., Adiels-Tegman M.: The prevalence of anaemia in the world. World Health Stat. Q 1985, 38, 302-16.
• 24. DHHS PHS Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tbe defects. MMWR, 1992, 41, 1- 7.
• 25. Doyle W., Crawford M.A. Wynn A.H. et al.: Maternal Magnesium intake and pregnancy outcome. Magnes. Res., 1989, 2, 205-10.
• 26. Duvekot E.J., de Groot C.J., Bioemenkamp K.W., et al.: Pregnant women with a low milk intake have an increased risk of developing preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol., 2002, 105, 11-4.
• 27. Expert Advisory Group. Folic acid the prevention of neural tube defects. London, Department of Health, 1992.
• 28. Folic acid fortification. Nutr. Rev., 1996, 54, 94.
• 29. Godfrey K.M., Barker D.J.P: Fetal nutrition and adult disease. Am. J. Clin. Nutr., 2000, 71(Suppl),1344S-52S.
• 30. Gregory J.F.: The bioavailability of folate. In: Folate in health and disease. Bailey L.B., ed. New York: Marcel Dekker, 1995.
• 31. Haggarty P., Abramovich D.R., Page K.: The effect of maternal smoking and ethanol on fatty acid transport by the human placenta. Br. J. Nutr., 2002, 87, 247- 52.
• 32. Hambidge K.M., Neidner K.H., Walravens P.A.: Zinc, acrodermatitis enteropathica, and congenital malformations. Lancet, 1975, i, 577.
• 33. Heiland I.B., Smith L., Saarem K.,et al.: Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics, 2003, 111, e39-44.
• 34. Hemminki E., Starfield B.: Routine administration of iron and vitamins during pregnancy: review of controlled clinical trials. Br. J. Obstet. Gynaecol., 1978, 85, 404-10.
• 35. Herbert V:. Folate and neural tube defects. Nutr. Today, 1992, November, 30.
• 36. Hercberg S., Preziosi P., Galan P.: Iron deficiency in Europe. Publ. Health. Nutr., 2001, 4, 537-45.
• 37. Honein M.A., Paulozzi L.J., Mathews T.J., et al.: Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. J. Am. Med. Assoc., 2001, 285, 2981- 6.
• 38. Hornstra G.: Essential fatty acids in mothers and their neonates. Am. J. Clin. Nutr., 2000, 71 (Suppl), 1262S-9S.
• 39. Institute of Medicine, National Academy of Science: Iron Deficiency Anemia: Recommended Guidelines for Prevention, Detection, and Management among US Children and Women in Childbearing Age. Washington, DC. National Academy Press,-1993.
• 40. Jackson A.A., Robinson S.M.: Dietary guidelines for pregnancy: a review of current evidence. Publ. Health Nutr., 2001, 4 (2B), 625-630.
• 41. King J.C.: Determinants of maternal zinc status during pregnancy. Am. J. Clin. Nutr., 2000, 71(Suppl), 1334S-43S.
• 42. Kleinman J.C.: Maternal Weight Gain During Pregnancy: Determinants and Consequences. NCHS Working Paper Series No.33. National Center for Health Statistics, Public Health Service, U.S. Department of Health and Human Services, Hyattsville, 1990.
• 43. Koebnick C., Heins U.A., Hoffmann I. et al.: Folate status during pregnancy in women is improved by long-term high vegetable intake compared with the average western diet. J. Nutr., 2001, 131, 733-39.
• 44. Kovacs L., Molnar B.G., Huhn E., et al.: Magnesium substitution in pregnancy. A prospective randomized double-blind study. Geburtshilfe Frauenheilkunde 1988, 48, 595-600.
• 45. Laurence K.M., James N., Miller M.H., et al.: Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. Br. Med. J., 1981, 282, 1509.
• 46. Lin-Fu J.S., Anthony M.A.: Folic acid and neural tube defects: A fact sheet for health care providers. Maternal and Child Health Bureau, Health Resources and Services Administration, Public Health Service, 1990.
• 47. Lucas A., Morley R., Cole T.J.: Breast milk and subsequent intelligence quotient in children born preterm. Lancet, 1992, 339, 261.
• 48. McDade T.W., Beck M.A., Kuzawa C.W., et al.: Prenatal undernurtirition and postnatal growth are associated with adolescent thymic function. J. Nutr., 2001, 131, 1225-1231.
• 49. Merialdi M., Carroli G., Villar J., et al.: Nutritional interventions during pregnancy for the prevention or treatment of impaired fetal growth: an overview of randomized controlled trials. J. Nutr., 2003, 133, 1626-31S.
• 50. Mikhail M.S., Anyaegbunam A., Garfinkel D. et al.: Preeclampsia and antioxidant nutrient: decreased plasma levels of reduced ascorbic acid, alfa-tocoferol, and beta-carotene in women with preeclampsia. Am. J. Obstet. Gynec., 1994, 171, 150.
• 51. Monsen E.R.: Dietary reference intakes for the antioxidant nutrients: vitamin C, vitamin E, selenium and carotenoids. J. Am. Diet. Assoc., 2000, 100, 637- 640.
• 52. MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet, 1991, 338, 131-7.
• 53. Naeye R.L.: Weight gain and the outcome of pregnancy. Am. J. Obstet. Gynecol., 1979, 135, 3-9
• 54. Narodowy Program Zdrowia 1996-2005. Ministerstwo Zdrowia i Opieki Społecznej. Międzyrestortowy Zespól Koordynacyjny Narodowego Programu Zdrowia. Warszawa, 1996.
• 55. National Health and Medical Research Council. Revised statement on the relationship between dietary folic acid and neural tube defects such as spina bifida. 115th session. Australia: NHMRC,1993.
• 56. Neuringer M., Anderson G.J., Connor W.E.: The essentiality of n-3 fatty acids for the development and function of the retina and brain. Annu. Rev. Nutr., 1988, 8, 517.
• 57. Neuringer M., Connor W.E.: N-3 fatty acids in the brain and retina: evidence for their essentiality. Nutr. Rev., 1986, 44, 285.
• 58. Neuringer M., Connor W.E., Lin D.S., et al.: Biochemical and functional effects of prenatal and postnatal omega-3 fatty acid deficiency on retina and brain in rhezus monkeys. Proc. Natl. Acad. Sei. USA 1986, 83, 4021.
• 59. Neuringer M., Connor W.E., Van Petten C. et al.: Dietary omega-3 fatty acid deficiency and visual loss in infant rhesus monkeys. J. Clin. Invest., 1984, 73, 272.
• 60. Nutrition During Pregnancy. Institute of Medicine, National Academy of Sciences. National Academy Press. Washington, D.C., 1990.
• 61. Olsen S.F., Hansen H.S., Sorensen T.I., et al.: Intake of marine fat, rich in (n- 3)-polyunsaturated fatty acids, may increase birthweight by prolonging gestation. Lancet, 1986, 2, 367-9.
• 62. Olsen S.F, Joensen H.D.: High liveborn birth weights in the Faroes: a comparison betweenbirth weights in the Faroes and in Denmark. J. Epid. Comm. Health, 1985, 39, 27-32.
• 63. Olsen S.F., Secher N.J.: Low consumption of seafood i early pregnancy as a risk factor for preterm delivery: prospective cohort study. Br. Med. J., 2002, 324, 447.
• 64. Olsen S.F., Secher N.J., Tabor A., et al.: Randomised clinical trials of fish oil supplementation in high risk pregnancies. Br. J. Obstet. Gynecol., 2000, 107, 382-95.
• 65. Olsen S.F., Sorensen J.D., Secher N.J., et al.: Randomised controlled trial of effect offish-oil supplementation on pregnancy duration. Lancet, 1992, 339, 1003-7.
• 66. Osendarp S.J.M., van Raaij J.M.A., Arifeen S.E. et al.: A randomized, placebo-controlled trial of the effect of zinc supplementation during pregnancy on pregnancy outcomes in Bangladeshi urban poor. Am. J. Clin. Nutr., 2000, 71, 114-9.
• 67. Recommended Dietary Allowances. 10th edition. Washington D.C. National Academy Press, 1989.
• 68. Rothman K.J., Moore L.L., Singer M.R. et al.: Teratogenicity of high vitamin A intake. N. Engl. J. Med., 1995, 333, 1369-73.
• 69. Scholl T.O., Hediger M.L., Fischer R.L. et al.: Anemia vs iron deficiency: Increased risk of preterm delivery in a prospective study. Am. J. Clin. Nutr., 1992, 55, 985.
• 70. Scholl T.O., Hediger M.L., Scholl J.J. et al.: Low zinc intake during pregnancy: its association with preterm and very preterm delivery. Am. J. Epid., 1993, 137, 1115-24.
• 71. Sebire N.J., Jolly M., Harris J.P .: Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int. J. Obes. Relat. Metab. Disord., 2001, 25, 1175-82.
• 72. Shoob H.D., Sargent R.G., Thompson S.J., et al.: Dietary methonine is involved in the etiology of neural tube defect-affected pregnancies in humans. J. Nutr., 2001, 131, 2653-8.
• 73. Sibai B.M., Villar L., Bray E.: Magnesium supplementation during pregnancy. A double-blind randomized controlled clinical trial. Am. J. Obstet. Gynecol., 1989, 161, 115-9-.
• 74. Sikorski S., Juszkiewicz T., Paszkowski T.: Zinc status in women with premature rupture of membranes at term. Obstet. Gynecol., 1990, 76, 675-7.
• 75. Smithells R.W., Nevin N.C, Seller M.J., et al.: Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet, 1983, 1, 1027.
• 76. Spatling L., Spatling G.: Magnesium supplementation in pregnancy: a double blind study. Br. J. Obstet. Gynecol., 1988, 95, 120-5.
• 77. Stasiak A., Słomko Z.: Suplementacja odżywiania kobiet ciężarnych. Klin. Perinatol. Gin., Supi VII: Niedobór jodu i jego skutki. Poznań, 1994.
• 78. Steegers-Theunissen R.P: Folate metabolism and neural tube defects: a review. Eur. J. Obstet. Gynecol., 1995, 61, 39.
• 79. Stene L.C., Ulriksen J., Magnus P, et al.: Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia, 2000, 43, 1093-8.
• 80. Szamotulska K, Szostak-Węgierek D.: Mala masa urodzeniowa a zespół X w wieku dorosłym („hipoteza Barkera"). Diabetologia Polska, 1999, 6, 56-61.
• 81. Transcript of the Folic Acid Subcommittee, Department of Health and Human Services; Arlington V.A., November 23 and 24, 1992.
• 82. Uauy R., Birch D.G., Birch E.E., et al.: Effect of dietary omega-3 fatty acids on retinal function of very-low-birth-weight neonates. Pediatr. Res., 1990, 28, 285.
• 83. Ubbink J.B.: Is an elevated circulating maternal homocysteine concentration a risk factor for neural tube defects? Nutr. Rev., 1995, 53, 173.
• 84. Vergel R.G., Sanchez L.R., Heredero B.L., et al.: Primary prevention of neural tube defects with folic acid supplementation. Cuban Experience Prenat Diagn., 1990, 10, 149.
• 85. Villar J., Repke J.T.: Calcium supplementation during pregnancy may reduce preterm delivery in high risk populations. Am. J. Obstet. Gynecol., 1990, 163, 1124.
• 86. Villar J., Repke J.T., Belizan J.M., et al.: Calcium supplementation reduces blood pressure during pregnancy: Results of a randomized controlled clinical trial. Obstet. Gynecol., 1987, 70, 317.
• 87. Viteri F.E.: The consequences of iron deficiency and anemia in pregnancy. W: Allen L., King J., Lönnerdal B., eds. Nutrient Regulation during Pregnancy, Lactation and Infant Growth. New York: Plenum Press, 1994, 127-39.
• 88. Wellinghausen N.: Immunobiology of gestational zinc deficiency. Br. J. Nutr., 2001, 85 (Suppl2), S81-6.
• 89. Westney O.E., Westney L.S., Johnson A.A., et al.: Nutrition, genital tract infection, hematologic values, and premature rupture of membranes among African American women. J. Nutr., 1994, 124, 987S-93S.
• 90. WHO Safe vitamin A dosage during pregnancy and lactation. Recommendations and report from a consultation. Micronutrient series. Geneva: World Health Organization, 1998, (WHO.NUT/98.4.).
• 91. Wild J., Sutcliffe M., Schorah C.J., Levene M.I.: Preventionof neural tube defects. Lancet, 1997, 350, 30-1.
• 92. Woods J.R. Jr, Plessinger M.A., Miller R.K.: Vitamins C and E: missing links in preventing preterm premature rupture of membranes? Am. J. Obstet. Gynecol., 2001, 185, 5-10.
• 93. Ziari S.A., Mireles VL., Cantu C.G., et al.: Serum vitamin A, vitamin E, and beta-carotene levels in preeclamptic women in northern Nigeria. Am. J. Perinatol., 1996, 13, 287-91.
• 94. Ziemlański S. (red): Normy żywienia człowieka. Fizjologiczne podstawy. PZWL, 2001, Warszawa.